Cargando…
Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol
INTRODUCTION: Population-wide interventions offer a pathway to tuberculosis (TB) and leprosy elimination, but ‘real-world’ implementation in a high-burden setting using a combined approach has not been demonstrated. This implementation study aims to demonstrate the feasibility and evaluate the effec...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006843/ https://www.ncbi.nlm.nih.gov/pubmed/35414551 http://dx.doi.org/10.1136/bmjopen-2021-055295 |
_version_ | 1784686745278742528 |
---|---|
author | Coleman, Mikaela Hill, Jeremy Timeon, Eretii Tonganibeia, Alfred Eromanga, Baraniko Islam, Tauhid Trauer, James M Chambers, Stephen T Christensen, Amanda Fox, Greg J Marks, Guy B Britton, Warwick J Marais, Ben J |
author_facet | Coleman, Mikaela Hill, Jeremy Timeon, Eretii Tonganibeia, Alfred Eromanga, Baraniko Islam, Tauhid Trauer, James M Chambers, Stephen T Christensen, Amanda Fox, Greg J Marks, Guy B Britton, Warwick J Marais, Ben J |
author_sort | Coleman, Mikaela |
collection | PubMed |
description | INTRODUCTION: Population-wide interventions offer a pathway to tuberculosis (TB) and leprosy elimination, but ‘real-world’ implementation in a high-burden setting using a combined approach has not been demonstrated. This implementation study aims to demonstrate the feasibility and evaluate the effect of population-wide screening, treatment and prevention on TB and leprosy incidence rates, as well as TB transmission. METHODS AND ANALYSIS: A non-randomised ‘screen-and-treat’ intervention conducted in the Pacific atoll of South Tarawa, Kiribati. Households are enumerated and all residents ≥3 years, as well as children <3 years with recent household exposure to TB or leprosy, invited for screening. Participants are screened using tuberculin skin testing, signs and symptoms of TB or leprosy, digital chest X-ray with computer-aided detection and sputum testing (Xpert MTB/RIF Ultra). Those diagnosed with disease are referred to the National TB and Leprosy Programme for management. Participants with TB infection are offered TB preventive treatment and those without TB disease or infection, or leprosy, are offered leprosy prophylaxis. The primary study outcome is the difference in the annual TB case notification rate before and after the intervention; a similar outcome is included for leprosy. The effect on TB transmission will be measured by comparing the estimated annual risk of TB infection in primary school children before and after the intervention, as a co-primary outcome used for power calculations. Comparison of TB and leprosy case notification rates in South Tarawa (the intervention group) and the rest of Kiribati (the control group) before, during and after the intervention is a secondary outcome. ETHICS AND DISSEMINATION: Approval was obtained from the University of Sydney Human Research Ethics Committee (project no. 2021/127) and the Kiribati Ministry of Health and Medical Services (MHMS). Findings will be shared with the MHMS and local communities, published in peer-reviewed journals and presented at international conferences. |
format | Online Article Text |
id | pubmed-9006843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-90068432022-05-02 Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol Coleman, Mikaela Hill, Jeremy Timeon, Eretii Tonganibeia, Alfred Eromanga, Baraniko Islam, Tauhid Trauer, James M Chambers, Stephen T Christensen, Amanda Fox, Greg J Marks, Guy B Britton, Warwick J Marais, Ben J BMJ Open Epidemiology INTRODUCTION: Population-wide interventions offer a pathway to tuberculosis (TB) and leprosy elimination, but ‘real-world’ implementation in a high-burden setting using a combined approach has not been demonstrated. This implementation study aims to demonstrate the feasibility and evaluate the effect of population-wide screening, treatment and prevention on TB and leprosy incidence rates, as well as TB transmission. METHODS AND ANALYSIS: A non-randomised ‘screen-and-treat’ intervention conducted in the Pacific atoll of South Tarawa, Kiribati. Households are enumerated and all residents ≥3 years, as well as children <3 years with recent household exposure to TB or leprosy, invited for screening. Participants are screened using tuberculin skin testing, signs and symptoms of TB or leprosy, digital chest X-ray with computer-aided detection and sputum testing (Xpert MTB/RIF Ultra). Those diagnosed with disease are referred to the National TB and Leprosy Programme for management. Participants with TB infection are offered TB preventive treatment and those without TB disease or infection, or leprosy, are offered leprosy prophylaxis. The primary study outcome is the difference in the annual TB case notification rate before and after the intervention; a similar outcome is included for leprosy. The effect on TB transmission will be measured by comparing the estimated annual risk of TB infection in primary school children before and after the intervention, as a co-primary outcome used for power calculations. Comparison of TB and leprosy case notification rates in South Tarawa (the intervention group) and the rest of Kiribati (the control group) before, during and after the intervention is a secondary outcome. ETHICS AND DISSEMINATION: Approval was obtained from the University of Sydney Human Research Ethics Committee (project no. 2021/127) and the Kiribati Ministry of Health and Medical Services (MHMS). Findings will be shared with the MHMS and local communities, published in peer-reviewed journals and presented at international conferences. BMJ Publishing Group 2022-04-11 /pmc/articles/PMC9006843/ /pubmed/35414551 http://dx.doi.org/10.1136/bmjopen-2021-055295 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Epidemiology Coleman, Mikaela Hill, Jeremy Timeon, Eretii Tonganibeia, Alfred Eromanga, Baraniko Islam, Tauhid Trauer, James M Chambers, Stephen T Christensen, Amanda Fox, Greg J Marks, Guy B Britton, Warwick J Marais, Ben J Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol |
title | Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol |
title_full | Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol |
title_fullStr | Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol |
title_full_unstemmed | Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol |
title_short | Population-wide active case finding and prevention for tuberculosis and leprosy elimination in Kiribati: the PEARL study protocol |
title_sort | population-wide active case finding and prevention for tuberculosis and leprosy elimination in kiribati: the pearl study protocol |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006843/ https://www.ncbi.nlm.nih.gov/pubmed/35414551 http://dx.doi.org/10.1136/bmjopen-2021-055295 |
work_keys_str_mv | AT colemanmikaela populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT hilljeremy populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT timeoneretii populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT tonganibeiaalfred populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT eromangabaraniko populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT islamtauhid populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT trauerjamesm populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT chambersstephent populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT christensenamanda populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT foxgregj populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT marksguyb populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT brittonwarwickj populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol AT maraisbenj populationwideactivecasefindingandpreventionfortuberculosisandleprosyeliminationinkiribatithepearlstudyprotocol |